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1 Introduction
Craniotabes of newborns, an ossification disturb-
ance of the skull bones, is considered a harmless
phenomenon, due to the incoordination between
the rapid growth of the brain and the calcification
process in the vertex during the last month of
gestation [1]. It is manifest most often in prema-
ture babies, but is seen often also in fullterm new-
borns. The incidence of craniotabes varies from 10
to 35 percent of all newborns [1]. The infants with
this defect have a normal calcium and phosphorus
level and the soft area calcifies spontaneously in a
few months.
The exact pathogenetic mechanism of craniotabes
in newborns has remained obscure. GRAHAM and
SMITH [6] recently supposed that early engage-
ment of the fetal head is essential for its manifesta-
tion. The major changes in the mineral metabolism
during pregnancy could also play a role in incor-
rect calcification of the parietal bones [9].
The aim of the present study was to investigate the
role of local factors, changes in calcium balance
and serum 25-OH-D3 levels in mother-neonate
pairs with the manifestation of craniotabes during
the end of gestation.
2 Material and methods
2.1 Definition of craniotabes
Diagnosis was based on the palpation examination
of the head of the newborn in the second or third
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day of life by the same pediatrician (JK). Diffuse
softening of the cranial bones around the sagittal
suture, or a local smooth (ping-pong) area were
used as criteria for craniotabes.
2.2 Patients
The first series consisted of 16 mother-newborn
pairs in a consecutive order from the beginning of
May 1980 until the end of July 1980 seen in the
University Central Hospital of Oulu. The mothers
were studied in the third postpartal day for the
concentrations of serum calcium (s-Ca), inorganic
phosphorus (s-Pi), alkaline phosphatase (s-AFOS)
and parathormone (s-PTH) and the parathormone
index (PTHind), calculated as s-Ca χ s-Pi/s-AFOS.
A 24-hour urine collection was performed for the
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determination of urinary calcium (dU-Ca) and
phosphorus (dU-Pi) excretion. The newborns were
studied in their third day of life for the concentra-
tions of s-Ca, s-Pi and s-AFOS and PTHind. A
control series consisted of 10 mothers without use
of any vitamin D during pregnancy, each with a
newborn without craniotabes, delivering at the
same time. In these mothers the same investigative
procedure was used as in the study group.
For the determination of serum 25-OH-D3 concen-
trations another series of 11 mothers and new-
borns with craniotabes was collected on the third
day after the delivery starting on October 1st until
the end of January 1981.
A control series for vitamin D3 studies consisted of
16 mothers of newborns without craniotabes
delivering at the same seasonal time.
The course of all 27 pregnancies of both the study
groups were analyzed retrospectively from the
case-notes of the mothers. Every pregnancy had
been followed up by the out-patient maternity
care units from the first trimester and thirteen of
them had also hospital controls including ultra-
sonic and biochemical examinations from the
second or third trimester.
2.3 Laboratory methods
The concentrations of s-Ca, s-Pi, dU-Ca and dU-Pi
were determined by a colorimetric method,
s-AFOS by an enzymatic method and PTH by an
RIA method with a 12.7 percent intra-assay
variation [2]. A specific protein binding method
using human carrier protein as a binding protein
was used in the determination of s-25-OH-D3,
which was separated from other vitamin D deriva-
tives by gaschromatography [7]. The lowest reliable
concentration determined by our method is
3 Mg/ml. ,.,
Statistical methods: A student's t-test was used in
the analysis of calcium studies and a MANN-
WHITNEY nonparametric test in the analysis of
vitamin D3 studies.
3 Results
The course of the pregnancy:
Eleven out of 27 mothers with a newborn with
craniotabes were primigravida; none had had more
than two earlier gestations. 21 of these mothers
completed an uneventful pregnancy. Four preg-
nancies were complicated by pre-eclampsia, one
by latent diabetes and one was a twin-pregnancy.
Clinical examination revealed engagement of the
fetal head within the pelvis before 33 weeks of
gestation in four cases, between the 33rd and 36th
week in two cases and in the rest thereafter. Two
out of thirteen ultrasonically examined fetuses
presented a late flattening type of biparietal
diameter growth retardation. The symphysis-
fundus growth was retarded in three pregnancies.
— A spontaneous uncomplicated delivery with
cephalic presentation took''place in all but two
pregnancies, which were delivered by a Cesarean
section.
Twelve out of these 27 newborns were females
and fifteen were males. The average birth weight
of the newborns was 3536 g (range 2800-4440 g),
birth height 50.4cm (range 46.5—53.0cm)
and head circumference 34.8cm (range 33.0—
36.5cm).
For laboratory findings, i.e. calcium and phos-
phorus metabolism see (Tab. I).
Tab. I. Laboratory findings (mean ± SD) in 16 mothers with a newborn with craniotabes.
Subjects
Mothers with a
newborn with
craniotabes
Controls
N
16
10
S-Ca
mmol/1
2.19*
±0.10
2.28
± 0.09 "
S-Pi
mmol/1
1.19
±0.12
1.19
±0.15
dU-Ca
mmol/24-h
3.22
±2.80
3.79
± 2.49
dU-Pi
mmol/24-h
30.6*
±8.9
39.9
±7.7
S-AFOS
U/l
290
±83
250
±50
S-PTH
1.4
±0.3
1.6
±0.6
PTHind
9.6
±3.0
10.6
±2.5
* p < 0.05 as compared with controls
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Tab. II. S-Ca, S-Pi and S-AFOS (mean ± SD) in 16 new-
borns with craniotabes and in normal newborns
N
S-Ca
mmol/1
S-Pi
mmol/1
S-AFOS
U/l
PTHind
Newborns with
craniotabes
16
2.30
±0.14
2.02
±0.31
435
± 115
11.4
±3.6
Normal
newborns
16
2.28
±0.13
1.98
±0.24
372
±76
12.3
±2.9
3.1 Mothers
The level of s-Ca in the mothers of newborns
with craniotabes was lower than in controls
(p < 0.05). The phosphate excretion in urine
was also decreased (p < 0.05). No significant
difference was found in the level of s-Pi, s-AFOS
or s-PTH between the study group and controls
(Tab. I).
3.2 Serum 25-OH-D3 (Fig. 1)
As expressed in Fig. 1 the levels of s-25-OH-D3 in
mothers of newborns with craniotabes and also in
the infants themselves were both low without
difference as compared with controls. In the study
group seven mothers out of 11, and in the control
group ten out of sixteen showed values below the
limit (10Mg/ml) considered to cause osteomalacia.
The values of 25-OH-D3 in non-pregnant controls
were higher (p < 0.001) than in mothers of both
study and control groups. A good correlation was
found between the serum levels of s-25-OH-D3 in
the mothers and their newborns.
3.3 Newborns
The mean concentrations of s-Ca (2.30 versus
2.28), phosphorus (2.02 versus 1.98) and s-AFOS
(435 versus 323) in newborns showed no signifi-
cant difference as compared to the controls.
4 Discussion
The clinical findings in the retrospective analysis
of 27 pregnancies of newborns with craniotabes
did not show any remarkable alterations that
would illuminate the aetiology of craniotabes.
Only in six cases the head of the fetus was engaged
before the 36th week of gestation, which is only a
little more than normal. In this light local factors
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Fig. 1. Serum 25-OH-D3 in unpregnant controls, in healthy mothers and newborns and in mothers with a newborn with
craniotabes. All groups have been studied in the same season.
J.Perinat.Med.il (1983)
130 Kokkonen et al., Newborn craniotabes
e.g. compression as suggested by GRAHAM and
SMITH [6] can not be considered as the only factor
for craniotabes, but they may have influence in
some cases.
We found a minor decrease in serum Ca concentra-
tions in mothers of newborns with craniotabes and
the dU-Pi excretion in urine was also decreased as
compared with controls. This might refer to
insufficient dietary intake of Ca and K or vitamin
D deficiency. The former was not possible to
evaluate retrospectively. Most mothers exhibited
also low values of vitamin D3 but the mean level
remained at the same level as compared with the
values in mothers of newborns without craniotabes
but significantly lower than in non-pregnant
controls. The lack of vitamin D3 is known to cause
demoralization of bones and craniotabes in older
infants and children [8] and it may be that slightly
more altered Ca-metabolism than normally [9] in
association with low s-25-OH-D3 concentrations in
the mothers during pregnancy could play some
role in the etiology of craniotabes in newborns.
In infants the mean level of vitamin D3 was the
same as in their mothers, but very low values were
not seen as often in newborns perhaps indicating
active transport in cases with lack of 25-OH-D3,
which usually shows equilibrium between the
mother and her child [4, 5]. The results clearly
indicate that vitamin D substitution during preg-
nancy is necessary also in this latitude [3] as most
mothers studied for s-25-OH-D3 concentrations
after the delivery showed values below the limit
considered to cause osteomalacia.
In conclusion we consider that the manifestation
of craniotabes during pregnancy is associated in
most cases with a minor alteration in the maternal
Ca and vitamin D metabolism but their final value
in its pathogenesis remains obscure.
Summary
Serum calcium and 25-OH-D3 in mothers of newborns
with craniotabes. The aim of this study was to investigate
whether calcium or vitamin D balance during late preg-
nancy have influence on the outcome of newborn cranio-
tabes. 27 mothers and their fullterm newborns with
craniotabes in two series were studied for clinical findings,
course of pregnancy and calcium and vitamin D metabo-
lism after the pregnancy. Calcium and phosphorus balance
were studied in the first 16 mother-newborn pairs and
compared to a control group. Serum 25-OH-D3 concen-
trations were determined in the next 11 pairs and com-
pared to a control group delivering in the same season and
also to unpregnant women. The course of pregnancy did
not show retrospectively any significant alterations and
the clinical findings except craniotabes of the newborns
were normal. In four cases the fetal head was engaged
before 33th of gestation. In mothers serum calcium level
was lower (p < 0.05) and the, excretion of phosphorus
decreased (p < 0.05) after the pregnancy as compared to
controls. The values of serum 25-OH-D3 were at the same
level in mothers and newborns with craniotabes as com-
pared to controls but the values of mothers were lower
(p < 0.001) as compared to unpregnant controls.
In conclusion, craniotabes of the newborns seems to have
no unique etiologic factor. The changes of calcium
and vitamin P metabolism during pregnancy may be
considered as predisposing factors in some cases and early
engagement in some other. Perhaps also other reasons can
be found.
Keywords: Alkaline phosphatase, craniotabes of newborns, parathormone, serum calcium, serum phosphate,
s-25-OH-D3.
Zusammenfassung
Serumkonzentrationen von Calcium und 25-OH-D3 bei
Müttern von Neugeborenen mit Kraniotabes
Die Fragestellung unserer Studie war, ob der Calcium-
bzw. Vitamin-D-Spiegel in der Spätschwangerschaft einen
Einfluß auf die Entstehung eines Kraniotabes hat. Wir
untersuchten 27 Mütter und ihre reifen Neugeborenen
mit Kraniotabes unter Berücksichtigung klinischer Para-
meter, des Schwangerschaftsverlaufs sowie des Calcium-
und Vitamin-D-Metabolismus nach der Schwangerschaft,
wobei wir 2 Gruppen bildeten. In der ersten Gruppe, die
16 Mütter mit ihren Neugeborenen umfaßte, bestimmten
wir Calcium und Phosphat und verglichen die Werte mit
einer Kontrollgruppe. Bei den übrigen 11 Paaren bestimm-
ten wir die 25-OH-D3-Konzentrationen im Serum und ver-
glichen sie mit einer Kontrollgruppe, die in derselben
Jahreszeit entbunden hatte sowie auch mit Werten nicht-
schwangerer Frauen. Der Schwangerschaftsverlauf zeigte
rückblickend keine Besonderheiten. Auch die klinischen
Befunde bei den Neugeborenen waren, mit Ausnahme des
Kraniotabes, normal. In 4 Fällen war der kindliche Kopf
bereits vor der 33. Schwangerschaftswoche im Becken
eingestellt. Bei diesen Müttern war im Vergleich zur
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Kontrolle nach der Schwangerschaft der Serumcalcium-
spiegel geringer (p < 0,05) und die Phosphatausscheidung
erniedrigt (p < 0,05). Die 25-OH-D3-Spiegel im Serum
von Müttern und deren Neugeborenen mit Kraniotabes
waren mit der Kontrollgruppe vergleichbar, die mütter-
lichen Spiegel jedoch erniedrigt, wenn man sie mit denen
von nichtschwangeren Frauen verglich (p < 0.001).
Zusammenfassend meinen wir, daß sich der Kraniotabes
beim Neugeborenen nicht auf einen einzigen ätiologischen
Faktor zurückführen läßt. Abweichungen im Calcium- und
Vitamin-D-Metabolismus können in einigen Fällen als
prädisponierende Faktoren angesehen werden; in anderen
Fällen mag die frühe Einstellung im Becken der Grund
sein. Darüber hinaus lassen sich vielleicht noch andere
Ursachen finden.
Schlüsselwörter: Alkalische Phosphatase, Calcium im Serum, Kraniotabes beim Neugeborenen, Parathormon, Phosphat
im Serum, 25-OH-D3 im Serum.
Resume
Calcemie et 2 5-O H-D 3 serique chez les meres de nouveaux-
nes presentant un cranio-tabes
Le but de cette 6tude est de determiner si Tequilibre cal-
cique et de la Vitamine D en fin de grossesse influe sur le
devenir du cranio-tabes du nouveau-ne. 27 meres et leurs
nouveaux-nes bien ä terme ayant un cranio-tabes, en deux
series, ont ete etudies quant aux donnees cliniques, au
deroulement de la grossesse, et au metabolisme calcique
et de la Vitamine D apres la grossesse. L'equilibre phos-
pho-calcique a ete etudie chez les 16 premieres paiies
mere-enfant et compare au groupe temoin. Les concentra-
tions en 25-OH-D3 serique ont ete mesurees chez les
11 paires suivantes et comparees au groupe temoin
accouche ä la meme saison et egalement ä des femmes
non enceintes. Retrospectivement, le deroulement de
la grossesse n'a pas montre d'anomalies significatives
et les donnees cliniques des enfants, ä Fexception du
cranio-tabes, etaient normales. La tete foetale etait
engagee avant la 3Seme semaine de gestation dans 4 cas.
Chez les meres, la calcemie est plus basse (p < 0,05) et
l'excretion du phosphore diminuee (p < 0,05) apres la
grossesse en comparaison avec les temoins. Les valeurs
de la 25-OH-D3 serique sont au meme niveau chez les
meres et les nouveaux-nes avec cranio-tabes que chez les
temoins, mais les valeurs des femmes enceintes sont
inferieures (p < 0,001) ä celles des femmes temoins non
enceintes.
En conclusion, le cranio-tabes du nouveau-ne ne semble
pas avoir un facteur etiologique unique. Les modifications
du calcium et du metabolisme de la Vitamine D peuvent
etre considerees comme des facteurs predisposants dans
certains cas et l'engagement precoce dans quelques
autres. D'autres raisons peuvent peut-etre aussi etre
trouvees.
Mot-cles: Calcium serique, cranio-tabes des nouveaux-nes, parathormone, phosphatases alcalines, phosphate serique,
25-OH-D3 serique.
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